Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

264.21 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
49 50 Next >
3 Biotech Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2025
In researching this article, we used AI to help make predictions for potential triple-digit return biotech stocks by 2025 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
15 Stocks Up, 15 Stocks Down: A Look At The Dow Jones Industrial Average Halfway Through 2023
The stock market rebounded in 2023 with top indexes trading higher after 2022, which saw market declines. 
Via Benzinga
Amgen Inc. Dividend Stock Analysis
The company has paid a cash dividend to shareholders every year since 2011 and has increased its dividend payments for 13 consecutive years. 
Via Talk Markets
How Is The Market Feeling About Amgen?
Via Benzinga
7 Analysts Have This to Say About Amgen
Via Benzinga
A Look Into Amgen Inc's Price Over Earnings
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Amgen Out, Rio Tinto In As Morgan Stanley Shuffles Dividend Deck
Via Benzinga
What Will Amgen Buy Next?
The biotech could pursue these two budget-friendly targets. 
Via The Motley Fool
5 High-Yielding Dividend Stocks That Are Bargain Buys
This is a good time for investors to load up on healthcare companies. 
Via The Motley Fool
5 Top Dividend Stocks to Buy in July 2023
All 5 of these dividends stocks appear undervalued. 
Via The Motley Fool
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $4,900 Today
Via Benzinga
Amgen's Debt Overview
Via Benzinga
Activision Blizzard Shares up 1.83% Amid Regulators' Blunders
Shares of Microsoft Corp. (NASDAQ: MSFT) declined 1.92% on June 26, more than the broader market, while Activision Blizzard Inc. (NASDAQ: ATVI) rose 1.83%. The S&P 500 declined 0.41% in the session. 
Via MarketBeat
Topics Stocks
Exposures US Equities
Next-Gen Weight-Loss Drugs Set To Up The Game From Ozempic And Mounjaro: WSJ
Via Benzinga
Why Viking Therapeutics Stock Is Crashing Today
Investors seem concerned about the company's competitive positioning in weight loss. 
Via The Motley Fool
Why Amgen Stock Slumped on Monday
Already under fire on the regulatory front, the company is hit with a price-target cut. 
Via The Motley Fool
Russian Insurrection Crushed: 5 Stocks That Continue To Have Exposure To The Country
Via Benzinga
4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire
Buy 'em and then just get out of the way. Time and these companies' long-term strength will take care of the rest. 
Via The Motley Fool
Moderating Inflation, a Tasty IPO, Bull Market Talk, and More
We've also got two stocks worth watching: Chevron and Burford Capital. 
Via The Motley Fool
Alleged Industrial Espionage Makes an Interesting Story
We also chat about Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment. 
Via The Motley Fool
How to Retire Rich: Biotech Stocks Edition
Thanks to its enormous and practically permanent relevancies, the biotech sector offers a great avenue for retirement planning stocks. 
Via InvestorPlace
Eli Lilly Just Lent Its Big Pharma Cachet To Verve's Nascent Gene-Editing Program For $60 Million
Eli Lilly inked a deal worth $60 million to get in on a gene-editing drug for elevated lipoprotein A. 
Via Investor's Business Daily
5 Stocks to Buy With Explosive 500% Potential
Take advantage of a bullish change in investor sentiment with these five stocks to buy for 500% upside potential. 
Via InvestorPlace
Is the Biotech Industry (IBB) Poised For A Major Breakout?
The current consolidation in the IBB signals a potential breakout might be looming as key moving averages have converged within a contracted price range. 
Via MarketBeat
Topics ETFs
Is AbbVie or Amgen the Better Bargain Buy Right Now?
These elite drugmakers are both working through a number of headwinds. 
Via The Motley Fool
ASCO 2023 – Claudin 6 Makes A Splash In Ovarian Cancer
This year’s 2023 American Society of Clinical Oncology Annual Meeting (ASCO 2023) provided a surprising amount of clinical data relevant to biopharma investors. 
Via Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
The 3 Best Long-Term Dividend Stocks to Buy in June
Build a solid investment portfolio with the best long-term dividend stocks and enjoy passive income for many years to come. 
Via InvestorPlace
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
49 50 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.